Automation of insulin bolus dose calculation in type 1 diabetes: a feasibility study

被引:2
|
作者
Singla, Rajiv [1 ]
Bindra, Jatin [2 ]
Singla, Ankush [2 ]
Gupta, Geetu [3 ]
Gupta, Yashdeep [4 ]
Aggarwal, Shivam [2 ]
机构
[1] Kalpavriksh Healthcare, Dept Endocrinol, Kalpavriksh Clin, 96,Sect 13, Delhi 110078, India
[2] Kalpavriksh Healthcare, Dept Hlth Informat, Delhi, India
[3] Kalpavriksh Healthcare, Dept Nutr, Delhi, India
[4] All India Inst Med Sci, Dept Endocrinol, Delhi, India
关键词
Type; 1; diabetes; Expert system; Bolus insulin dose prediction; Carbohydrate counting;
D O I
10.1007/s13410-022-01054-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Diabetes care in type 1 diabetes has remained a challenge over time. Ability to count carbohydrates in every meal and varying insulin dose according to individual insulin/carbohydrate ratio allows people with type 1 DM to have wider food choices with better glycemic control. Difficulties in carbohydrate counting may largely be solved by use of technology. Methods This work was done at the endocrine unit of a superspeciality centre involved in care of people with type 1 diabetes. The process of development of software and its preliminary application and results from its use in clinical care in a small group of interested patients is presented in this manuscript. Carbohydrate counting tool for Indian foods was developed, and subsequently, bolus dose calculation was automated by using the reinforcement algorithm in an android app platform named "T1-Life". Data on app usability and acceptability is documented in this pilot study report. Results Five patients completed 3 months of this app usage. Among five people with combined usage over 115 patient weeks, a total of 2661 insulin dose predictions were made. This translates to 3.31 patient-initiated bolus dose predictions per day. Of the total bolus dose predictions made, 82% were accepted by the participants. With usage of app, time in range (70-180 mg/dl) increased by an average of 16.67% in children who used CGMS in their first week as well as last week of observation. Conclusion T1-life, integrated carbohydrate counting and reinforcement-based insulin bolus dose prediction system, has good patient usability and acceptability.
引用
收藏
页码:66 / 71
页数:6
相关论文
共 50 条
  • [21] Low-Dose Glucagon Bolus Treats Hypoglycemia in Type 1 Diabetes
    Ranjan, Ajenthen
    Schmidt, Signe
    Madsbad, Sten
    Holst, Jens Juul
    Norgaard, Kirsten
    DIABETES, 2015, 64 : A104 - A104
  • [22] The use of bolus insulin and advancing insulin therapy in type 2 diabetes
    Karl D.M.
    Current Diabetes Reports, 2004, 4 (5) : 352 - 357
  • [23] The immediate Impact of the COVID-19 Vaccination on the Time in Range and the Bolus Insulin Dose in People with Type 1 Diabetes - Subgroup Analysis of a multicenter Study
    Aberer, Felix
    Moser, Othmar
    Sourij, Caren
    Aziz, Faisal
    Ziko, Haris
    Muller, Alexander
    Obermayer, Anna M.
    Kojzar, Harald
    Pferschy, Peter N.
    Leitner, Marlies
    Lenz, Jacqueline
    Abbas, Farah
    Banfic, Tamara
    Eckstein, Max Lennart
    Wachsmuth, Nadine
    Tripolt, Norbert
    Kaser, Susanne
    Mader, Julia K.
    Sourij, Harald
    WIENER KLINISCHE WOCHENSCHRIFT, 2021, 133 (SUPPL 6) : 222 - 222
  • [24] Experience with Insulin-Bolus Calculator in Diabetes Type 1 Patients in Treatment on Basal-Bolus Regimen
    Tejera, Cristina
    Miguel Morales, Francisco
    Maria Lopez, Ana
    Galvan, Beatriz
    Delgado, Esther
    Beato, Pilar
    Hernandez, Virginia
    DIABETES, 2014, 63 : A596 - A596
  • [25] Subcutaneous low-dose glucagon bolus in the treatment of mild hypoglycaemia in insulin pump treated patients with type 1 diabetes
    Ranjan, A.
    Schmidt, S.
    Madsbad, S.
    Holst, J. J.
    Norgaard, K.
    DIABETOLOGIA, 2015, 58 : S418 - S418
  • [26] Insulin degludec in combination with bolus insulin aspart is safe and effective in children and adolescents with type 1 diabetes
    Thalange, Nandu
    Deeb, Larry
    Iotova, Violeta
    Kawamura, Tomoyuki
    Klingensmith, Georgeanna
    Philotheou, Areti
    Silverstein, Janet
    Tumini, Stefano
    Ocampo Francisco, Ann-Marie
    Kinduryte, Ona
    Danne, Thomas
    PEDIATRIC DIABETES, 2015, 16 (03) : 164 - 176
  • [27] Improving the estimation of mealtime insulin dose in adults with type 1 diabetes: Normal Insulin Demand for Dose Adjustment (NIDDA study)
    Brand-Miller, J. C.
    Bao, J.
    Gilbertson, H. R.
    Gray, R.
    Munns, D.
    Howard, G.
    Petocz, P.
    Colagiuri, S.
    DIABETOLOGIA, 2011, 54 : S400 - S400
  • [28] Efficacy and feasibility of basal-bolus insulin regimens and a discharge-strategy in hospitalised patients with type 2 diabetes - the HOSMIDIA study
    Perez, A.
    Reales, P.
    Barahona, M. J.
    Romero, M. G.
    Minambres, I.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2014, 68 (10) : 1264 - 1271
  • [30] Insulin dose and weight profiles of pre- and post-meal insulin glulisine in a basal-bolus regimen with insulin glargine in patients with Type 1 diabetes
    Klaff, L
    Rosenstock, J
    Garg, S
    Souhami, E
    Ways, K
    DIABETOLOGIA, 2004, 47 : A300 - A300